top of page

IN THE NEWS

WRITTEN ARTICLES

city_of_hope_logo.jpeg

City of Hope

"AOH 1996: The Olive in Every Cancer Cocktail"

July 28, 2025
Read More >

images.png

The Cancer Letter

"From 'undruggable' target to clinical potential: The journey of AOH1996"

June 20, 2025
Read More >

Group 1290.png

LA Times

"City of Hope Study Demonstrates Proof of Concept for Targeted New Approach to Treat Pancreatic Cancer"

April 9, 2025
Read More >

city_of_hope_logo.jpeg

City of Hope

"Targeted chemotherapy kills all tumor cells in preclinical research"

August 7, 2023
Read More >

Group 1289.png

Metro

"Cancer-killing pill that annihilates tumours hailed as ‘holy grail’ breakthrough"

August 4, 2023
Read More >

Group 1291.png

News Medical - Life Sciences

"New PCNA inhibitor AOH1996 shows selective cancer cell killings and tumor suppression potential"

August 4, 2023
Read More >

earthdotcom_logo.jpeg

Earth.com

"'Holy grail' molecule kills all types of solid cancer tumors"

August 4, 2023

Read More >

Group 1288.png

The Independent

"Cancer breakthrough as groundbreaking pill found to ‘kill tumours’"

August 2, 2023

Read More >

Group 1292.png

The Economic Times

"Game-changing Cancer-killing molecule unveiled by scientists; targets tumors, spares healthy cells"

August 2, 2023

Read More >

city_of_hope_logo.jpeg

City of Hope

"City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research"

August 1, 2023
Read More >

city_of_hope_logo.jpeg

City of Hope

"Cancer Center Announces First Patient Has Received City of Hope’s Novel, Potentially Cancer-Stopping Pill"

October 19, 2022
Read More >

RLLNEWLOGO.png

Included herein is information regarding RLL, LLC which may include, among other information, financial and/or scientific projections and prospects. Please note that the projections are based upon assumptions, some of which may change substantially before a confidential memorandum or other offering materials are prepared, some or all of which may not materialize. The information provided does not constitute any offer to sell or any solicitation of any offer to purchase any security, which offer will be made, if at all, only by a confidential memorandum or other offering materials prepared for such use and including applicable risk factors for the Company's offering and information regarding the securities laws of the applicable jurisdictions in which offers and sales are intended to occur.

© 2026 by RLL, LLC.

bottom of page